Home Credit Ratings and Research Fitch Research

Teva Pharmaceutical Industries Limited - Ratings Navigator

Published Aug 04, 2015

3 pages (2112 words) — Published Aug 04, 2015

Price US$ 500.00 | Buy this Report Now

About This Report

Brief Excerpt:

...Most of Teva's branded products are set to lose market exclusivity in coming years, though its R&D pipeline could boost longer term growth. The addition of Allergan's generics business should help offset this weakness....

Report Type:

Navigator

Company(ies)

Teva Pharmaceutical Industries Ltd. , Teva Pharmaceutical Finance Netherlands II BV , Teva Pharmaceutical Finance II B.V. , Teva Pharmaceutical Finance IV, LLC , Teva Pharmaceutical Finance II, LLC , Teva Pharmaceutical Finance Company B.V. , Teva Pharmaceutical Finance Company, LLC , Teva Pharmaceutical Finance IV B.V. , Teva Pharmaceuticals USA Inc. , Teva Pharmaceutical Finance V B.V.

Ticker(s)

TEVA

Issuer

Teva Pharmaceuticals USA, Inc.

Format:

PDF

Fitch Maintains Teva Pharmaceuticals' Ratings on Negative Watch – 2016/04/20 – US$ 149.00

Fitch Downgrades Teva Pharmaceuticals; Rates New Bonds 'BBB' – 2016/07/20 – US$ 149.00

Fitch Affirms 47 U.S. Healthcare Companies' Ratings – 2015/02/13 – US$ 300.00

Fitch Wire+: Generic Pharma Ratings Face Pressure From M&A Surge – 2015/08/13 – US$ 999.00

Teva Pharmaceutical Industries Limited - Ratings Navigator – 2016/04/20 – US$ 500.00

Fitch Rates Teva's Euro Bond Offering 'BBB+' – 2015/03/24 – US$ 149.00

Fitch: Generic Copaxone Approval Could Prompt Losses At Teva – 2015/04/17 – US$ 149.00

Fitch Places Teva Pharmaceutical's Ratings on Watch Negative on Proposed Mylan Acquisition – 2015/04/22 – US$ 149.00

Fitch: Teva Remains on Watch Negative on Allergan Generics Acquisition – 2015/07/28 – US$ 149.00

Fitch: Generic Pharma Ratings Face Pressure From M&A Surge – 2015/08/13 – US$ 149.00

More from Fitch Research

Fitch Research—Fitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.

About the Author

Cite this Report


MLA:	Fitch Research. "Teva Pharmaceutical Industries Limited - Ratings Navigator" Aug 04, 2015. Alacra Store. May 14, 2025. <http://www.alacrastore.com/fitch-credit-research/Teva-Pharmaceutical-Industries-Limited-Ratings-Navigator-869392_report_frame>

APA:	Fitch Research. (). Teva Pharmaceutical Industries Limited - Ratings Navigator Aug 04, 2015. New York, NY: Alacra Store. Retrieved May 14, 2025 from <http://www.alacrastore.com/fitch-credit-research/Teva-Pharmaceutical-Industries-Limited-Ratings-Navigator-869392_report_frame>

US$ 500.00

$ £ €

Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

Example Report

Click to View Sample Report

More Research

Search all our Credit Research from one place.